Tumor vaccination involving a humoral immune response against self-proteins

Details for Australian Patent Application No. 2011229518 (hide)

Owner Universitatsmedizin der Johannes Gutenberg-Universitat Mainz BioNTech AG

Inventors Klamp, Thorsten; Sahin, Ugur; Tureci, Ozlem; Koslowski, Michael; Hiller, Thomas; Schumacher, Jens

Agent Dibbens Intellectual Property

Pub. Number AU-A-2011229518

PCT Pub. Number WO2011/113546

Priority 10002775.4 16.03.10 EP; 10016216.3 30.12.10 EP

Filing date 9 March 2011

Wipo publication date 22 September 2011

International Classifications

C07K 14/02 Peptides having more than 20 amino acids

A61K 39/29 Medicinal preparations containing antigens or antibodies - Hepatitis virus

C07K 14/47 Peptides having more than 20 amino acids

Event Publications

30 August 2012 PCT application entered the National Phase

  PCT publication WO2011/113546 Priority application(s): WO2011/113546

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011229523-A cooking hob

2011229504-Polymer latex useful for the production of textile floor coverings